| 51 |
20477830 | KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells. | 2010 Nov |
1 |
| 52 |
20619636 | Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL. | 2010 Sep |
1 |
| 53 |
22545969 | Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy. | 2010 Nov |
1 |
| 54 |
19240170 | Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. | 2009 Mar 1 |
1 |
| 55 |
19317621 | The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis. | 2009 Jun |
7 |
| 56 |
19328230 | Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation. | 2009 Jun 15 |
1 |
| 57 |
19414365 | Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. | 2009 Apr |
1 |
| 58 |
19578044 | Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation. | 2009 Sep |
1 |
| 59 |
19887550 | Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. | 2009 Nov |
1 |
| 60 |
19934315 | Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity. | 2009 Dec 15 |
2 |
| 61 |
18376141 | Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol. | 2008 May |
3 |
| 62 |
18451495 | Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. | 2008 May |
1 |
| 63 |
18566236 | Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells. | 2008 Jun |
1 |
| 64 |
18585380 | Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins. | 2008 Sep 4 |
1 |
| 65 |
17275076 | Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells. | 2007 Apr |
6 |
| 66 |
17311906 | Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. | 2007 Jun |
1 |
| 67 |
17383050 | Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma. | 2007 Jun |
1 |
| 68 |
17399942 | Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. | 2007 Jul |
2 |
| 69 |
17492131 | Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells. | 2007 May |
1 |
| 70 |
17619073 | Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. | 2007 Nov |
3 |
| 71 |
17848273 | Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer. | 2007 |
5 |
| 72 |
18059167 | Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma. | 2007 Dec |
1 |
| 73 |
16188300 | Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells. | 2006 Feb |
1 |
| 74 |
16331250 | Involvement of Bcl-X(L) deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells. | 2006 Apr 27 |
3 |
| 75 |
16424027 | Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. | 2006 Jan 15 |
3 |
| 76 |
16442262 | Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. | 2006 Sep |
1 |
| 77 |
16525642 | Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production. | 2006 Apr |
1 |
| 78 |
16533421 | Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer. | 2006 Jan |
1 |
| 79 |
16549753 | Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. | 2006 Mar |
1 |
| 80 |
15661210 | Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. | 2005 Feb |
2 |
| 81 |
15958577 | Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2. | 2005 Jun 15 |
1 |
| 82 |
16020667 | Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. | 2005 Jul |
3 |
| 83 |
16115953 | Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. | 2005 Aug 15 |
1 |
| 84 |
15010843 | Modulation of Janus kinase 2 by cisplatin in cancer cells. | 2004 Apr |
1 |
| 85 |
15026553 | Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells. | 2004 Mar |
1 |
| 86 |
15141012 | Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma. | 2004 May |
1 |
| 87 |
15156398 | Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. | 2004 Jul |
1 |
| 88 |
15315167 | Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines. | 2004 |
4 |
| 89 |
15375532 | Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells. | 2004 Oct |
2 |
| 90 |
15566959 | Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells. | 2004 |
1 |
| 91 |
12536078 | Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines. | 2003 Feb 10 |
1 |
| 92 |
12950722 | Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. | 2003 Oct |
1 |
| 93 |
11734333 | Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. | 2002 Jan 10 |
1 |
| 94 |
11857368 | Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. | 2002 Feb 20 |
4 |
| 95 |
11948488 | Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. | 2002 May 1 |
1 |
| 96 |
12667321 | [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines]. | 2002 Nov |
6 |
| 97 |
11368186 | Targeting superoxide dismutase to renal proximal tubule cells inhibits mitochondrial injury and renal dysfunction inuduced by cisplatin. | 2001 Mar 1 |
1 |
| 98 |
11384107 | Telomerase activity and p53-dependent apoptosis in ovarian cancer cells. | 2001 Jun 1 |
1 |
| 99 |
10974635 | Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells. | 2000 Sep |
1 |
| 100 |
10397248 | Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. | 1999 Jul 1 |
1 |